Conclusive evidence has revealed that the potential of NF-κB signaling to bind to DNA leads to the expression of survivin and X-linked inhibitor of apoptosis (XIAP) and, eventually, induction of apoptosis in different cancer cell types, indicating the role of activated NF-κB in moderating chemoresistant compounds [71, 72]. This evidence concerns the gene NFKB1 and cancer.